DrugPatentWatch Database Preview
PEGINTRON Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Tradename: PEGINTRON
| Patents: | 30 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for PEGINTRON |
Recent Clinical Trials for PEGINTRON
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Third Affiliated Hospital, Sun Yat-Sen University | N/A |
| Rockefeller University | Phase 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
Pharmacology for PEGINTRON
| Ingredient-type | Interferon Alfa-2b Interferon-alpha |
Company Disclosures: US Patents for PEGINTRON
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | PEGINTRON | peginterferon alfa-2b | VIAL | 103949 | 001 | 2001-01-19 | Start Trial | Schering Corporation (Kenilworth, NJ) | 2015-11-02 | RX | Orphan | company |
| Schering | PEGINTRON | peginterferon alfa-2b | VIAL | 103949 | 001 | 2001-01-19 | Start Trial | Enzon, Inc. (Piscataway, NJ) | 2013-11-10 | RX | Orphan | company |
| Schering | PEGINTRON | peginterferon alfa-2b | VIAL | 103949 | 001 | 2001-01-19 | Start Trial | Enzon, Inc. (Piscataway, NJ) | 2013-11-10 | RX | Orphan | company |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for PEGINTRON
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | PEGINTRON | peginterferon alfa-2b | VIAL | 103949 | 001 | 2001-01-19 | Start Trial | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | 2031-04-05 | RX | Orphan | search |
| Schering | PEGINTRON | peginterferon alfa-2b | VIAL | 103949 | 001 | 2001-01-19 | Start Trial | Abbott Laboratories (Abbott Park, IL) | 2023-03-24 | RX | Orphan | search |
| Schering | PEGINTRON | peginterferon alfa-2b | VIAL | 103949 | 001 | 2001-01-19 | Start Trial | Intermune, Inc. (Brisbane, CA) | 2025-03-08 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for PEGINTRON
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1113299 | Start Trial |
| New Zealand | 197572 | Start Trial |
| India | 248DEN2012 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
